According to the latest research by InsightAce Analytic, the Genetically Engineered Animal Models & Services Market is valued at USD 1.4 Bn in 2024, and it is expected to reach USD 3.8 Bn by the year 2034, with a CAGR of 10.3 % during the forecast period of 2025-2034.
Global Genetically Engineered Animal Models & Services Market 2025-2034 full Research Repot latest version is now available.
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/3043
Genetically engineered animal models are key for biomedical research, enabling studies of gene function, diseases, and drug development using techniques like CRISPR and transgenesis. Services include model creation, breeding, cryopreservation, phenotyping, and drug screening, offered by providers like Charles River.
The main market growth drivers are the rising incidence of chronic illnesses, rising R&D expenditures, and developments in genetic engineering technologies. Understanding the pathogenesis of these illnesses and creating efficient treatments depend heavily on genetically engineered animal models & services.
Genetically modified mice models are frequently employed in cancer research to examine tumour start, development, and metastasis. Another important factor propelling the market is the rising investments made by biotechnology and pharmaceutical businesses in research and development.
List of Prominent Players in the Genetically Engineered Animal Models & Services Market:
Charles River Laboratories
Envigo
GenOway
Celerion
Crown Bioscience
Horizon Discovery
Crown Bioscience
Jackson Laboratory
Taconic Biosciences
In Vivo Therapeutics
BioIVT
Celerion
Expert Knowledge, Just a Click Away: https://calendly.com/insightaceanalytic/30min?month=2025-04
Market Dynamics:
Drivers-
The market for genetically engineered animal models & services is undergoing a revolution due to continuous developments in genetic engineering technology, especially CRISPR/Cas9. Researchers can quickly and accurately alter the DNA of animal models using the precise and effective gene-editing technique CRISPR/Cas9.
According to a report by the National Human Genome Research Institute (NHGRI), the number of scholarly papers addressing CRISPR has expanded dramatically from 100 in 2012 to over 16,000 in 2020. The market is expanding as a result of the CRISPR/Cas9 technology’s ability to create increasingly complex and disease-relevant animal models.
Additionally, the market for genetically altered animal models and services is poised to benefit greatly from the rising demand for humanized animal models. Genetically altered animals with human DNA, cells, or tissues are known as “humanized animal models,” and they are used to anticipate better how people will react to medications and illnesses. These models are especially useful in the domains of infectious illnesses, regenerative medicine, and immuno-oncology.
Challenges:
One major barrier to the market is the relatively expensive expense of creating and maintaining genetically engineered animal models & services. In order to create genetically modified animals, intricate procedures like breeding, embryo transfer, and genetic modification are needed, which call for specialized facilities, tools, and knowledgeable staff.
Due to their high cost, animal models are not as accessible to university institutions and smaller research companies with tighter resources. Additionally, the market for genetically engineered animal models & services has ethical issues related to the use of animals in research. The public and animal welfare organizations have voiced concerns over animal suffering and pain during genetic alteration and experimentation.
Regional Trends:
The North American Genetically Engineered Animal Models & Services market is likely to report a major market revenue share because it has an advanced research infrastructure that includes reputable universities, research facilities, and biotechnology businesses. This infrastructure makes it easier to create, maintain, and use animal models that have undergone genetic engineering.
North America is home to the headquarters of several of the biggest and most significant biotechnology and pharmaceutical corporations in the world. These businesses have a lot of money to spend on developing drugs using genetically engineered animal models & services.
Besides, over the projection period, Asia Pacific is expected to increase at the fastest rate, encouraged by the growing number of life sciences research projects and the strict laws governing animal experimentation. Clear regulatory frameworks in Asia Pacific govern the use of genetically modified animals in research.
Researchers and businesses can manage the ethical and regulatory implications of employing these models in a supportive environment with clear norms and standards.
Unlock Your GTM Strategy: https://www.insightaceanalytic.com/customisation/3043
Segmentation of Genetically Engineered Animal Models & Services Market-
By Type of Services-
Custom Model Development
Consultation Services
Model Validation
Breeding Services
Maintenance Services
By Application-
Oncology
Immunology
Metabolic Disorders
Cardiovascular Diseases
Neurological Disorders
By End-User-
Biotechnology Companies
Pharmaceutical Companies
Contract Research Organizations
Academic and Research Institutes
Government Organizations
By Region-
North America-
The US
Canada
Europe-
Germany
The UK
France
Italy
Spain
Rest of Europe
Asia-Pacific-
China
Japan
India
South Korea
South East Asia
Rest of Asia Pacific
Latin America-
Brazil
Argentina
Mexico
Rest of Latin America
Middle East & Africa-
GCC Countries
South Africa
Rest of the Middle East and Africa
Read Overview Report- https://www.insightaceanalytic.com/report/genetically-engineered-animal-models–services-market/3043
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact us:
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
info@insightaceanalytic.com
![[Citibank] – Various Mutual Funds Investment Options Provided by Citibank in UAE](https://tunisiaweekly.com/wp-content/uploads/2023/09/Arab-Newswire-Press-Release-Distribution-to-Media-Arab-World-and-MENA-regions-1-120x36.png){kind=small}
